Reliable Medications
These doctor-prescribed weekly treatments are personalized medications known as Semaglutide or GLP-1, and dual acting GLP-1/GIP tailor-made for each patient. Combining the actions of GLP-1 receptor agonists with GIP (glucose-dependent insulinotropic polypeptide) offers a dual approach in managing weight and improving glycemic control.
Whenever we consume food, specific hormones, including GLP-1 and GIP, are naturally released in our body, triggering a sensation of fullness. These medications target the brain, emulating that sense of fullness, curbing appetite, delaying stomach emptying, and ultimately reducing your daily calorie intake.
Furthermore, your body has a “set point,” the weight range at which your body naturally tends to stabilize. The treatment plan aims to establish a new, lower set point after you’ve reached your desired weight. This innovative approach is designed to help maintain long-term weight management more effectively.
It’s essential to note that approximately 70% of American adults grapple with obesity or overweight conditions, which pose significant health risks. These conditions are associated with leading causes of mortality, including heart disease, stroke, and diabetes, and are linked to an elevated risk of certain types of cancer.
By addressing weight issues with this comprehensive treatment, patients have a promising avenue towards improving their health and reducing the risks associated with obesity and overweight conditions..
Losing 5% to 10% of body weight through dietary adjustments and increased physical activity has been shown to reduce the risk of cardiovascular disease in adults dealing with obesity or being overweight.
